Modules
Lakeside Clinical Group, Inc.
Customer 41770
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ | Vendor | 81bb9ab0d2660a2b4bd7c57493a50d1f8faaf26f81c9f91cb3b0c17594d761b8
- Assigned Reps
- Priya Sandoval
- Website
- —
- Active Opportunity Count
- 35
- Published Count
- 11
- Revenue Base
- 10135.02
- Known GPBase
- 1821.1499999999999
- Analyzer Platforms
- Beckman Access / DxI | Olympus / Beckman AU | Horiba
- Product Groups
- Beckman Access | Olympus | Horiba | Parts Group
- Recommended Contact
- Xander Palladino
- Backup Contact
- Talia Garrow | Partner | talia.garrow@lakesideclinicalgroupinc.com | (331) 444-4249
- Last Meaningful Activity
- 2025-11-03
- Customer Memory
- Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Olympus / Beckman AU. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement N/A. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Horiba. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-d8c13bf38c8e466c833ba23085fd6a6e939cfdbcf01ea1810cdcdb3d101f33f2 | Customer 41770 | Item 4877 | Candidate CAND-f67f45146d5ce72094f4f651cab46c0da5db79370a4f86c615a1a4d99a7c41b1 | Customer 41770 | Order 52610 | Item 4954 | Candidate CAND-ac6f916cbb1d93c3fb105a5e285cd2057862a9330e6e62ec569d1d011272ae03 | Customer 41770 | Order 52168 | Item 11335 | Candidate CAND-76dd5e77797ca402c1ca1530f9a994207d56f3d29103f28a5ba1eeeb1a789eea | Customer 41770 | Quote 30145 | Item 12675 | Candidate CAND-5a384845f19109059f673b2bf64ebd57946f6ac0e144529f0716f6b9ed92c58d | Customer 41770 | Order 51799 | Item 12163 | Candidate CAND-72b776f780d393949d127f2ccb347129dc5c7fa9fa546be7f1485bba00f3deaa | Customer 41770 | Order 52947 | Item 14767 | Candidate CAND-acdd9dd8ebc8dc44f67532b0e259022ebbdb238448b4eb44061fab5ed6605166 | Customer 41770 | Order 52610 | Item 5019 | Candidate CAND-9127ff4aa6176ce0dc5984670e80b335ffdae94e2ec5ad4ecf3fcb9efe0a3c59 | Customer 41770 | Order 51426 | Item 10576 | Candidate CAND-0f941102e3995f95fd3d5cfc1c483024d090587e08121acc1e5d433ac98d95b3 | Customer 41770 | Order 52946 | Item 4953 | Candidate CAND-94add5d84d50d8c1ca63a51f92d75cd95fc3c4280fd310903d8a384cb183381d | Customer 41770 | Order 52610 | Item 4252 | Candidate CAND-dca93b71437c75a8c286d482dee4170042aa51b75a1a91cc1011c989668c2aa9 | Customer 41770 | Order 52610 | Item 4250
Opportunities (38)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cb6e06bd2c1245b056a9079815863e6c2c182c1819771cc0e1d9b50d08c9df54 | OPP-573302a9e57c2ce6695049e8982696a516490f5c94f7d66dd37f2c836c3e4011 | SER-a59321effa253457f8c2a27b90cf1bc0b4bd3ace5d46eb219fa6c34f5e1552b6 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | B24838 | B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | — | 52610 | 15 completed purchases over 364 days; median interval 22.5 days; expected reorder 2026-07-16; Suppressed by Open Order by 25 days. | 787.5 | 1050 | 1312.5 | 438.75 | 585 | 731.25 | 72.72 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-cb6e06bd2c1245b056a9079815863e6c2c182c1819771cc0e1d9b50d08c9df54 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5a384845f19109059f673b2bf64ebd57946f6ac0e144529f0716f6b9ed92c58d | OPP-b08ede3eba94336652bd91e111c06fbacd6e86363b4b84003662c40e4892659f | SER-c94bba89ae0cc2588cc69b1e261da4e16d7c6f41008ef88c55853f6bebf2d445 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6195 | OSR6195 Olympus HDL-C (HDL Cholesterol) Reagent, 4 x 30 mL & 4 x 10 mL | — | 51799 | 7 completed purchases over 301 days; median interval 42.5 days; expected reorder 2026-06-22; High Risk by 49 days. | 562.5 | 750 | 937.5 | 170.04 | 226.72 | 283.4 | 66.94 | Medium | False | False | — | CALL | Candidate CAND-5a384845f19109059f673b2bf64ebd57946f6ac0e144529f0716f6b9ed92c58d | Customer 41770 | Order 51799 | Item 12163 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | OPP-9071b47ae445ecb1eb90fabad158d04ad4c2e23eb3eee5fb6d8ab84ea1b9cd7e | SER-caafaa340c0356fa4c4488ab7edba0741c72511d42456f37d8a22dc8e550736a | Needs Validation | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33880 | 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | — | 51426 | 10 completed purchases over 272 days; median interval 19.0 days; expected reorder 2026-05-19; High Risk by 83 days. | 236.25 | 315 | 393.75 | 156.43 | 208.57 | 260.72 | 66.83 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-417d43e14a2b1975b36266df087a24f1742aa42a0d46c3e9fdd9d1d0c2d30179 | OPP-71143f2141ec2b7a5c04d0e677d8338ff76a64cbd375280ba5dd5c186cd71337 | SER-3ffb34553a3d75346f8f538e699aa8e326ed1d3bb0d96bda411239e49232891c | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A12985 | A12985 TPO Antibody, Access, 2 x 50 tests | — | 52610 | 11 completed purchases over 364 days; median interval 30.5 days; expected reorder 2026-07-21; Suppressed by Open Order by 20 days. | 298.5 | 398 | 497.5 | 196.73 | 262.3 | 327.88 | 66.03 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-417d43e14a2b1975b36266df087a24f1742aa42a0d46c3e9fdd9d1d0c2d30179 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-427d184d0e09b1f0197e5603ede5a1acfcc42dd228df04d7a42433b7545f2b17 | OPP-0a78e6e3ec520d3093e06953d47cda7273d417924117cb2d01e7f211c47209f1 | SER-065d8b1651cd87fb5e4870a1b55c68f0bb7e9691cb5c73a0f9f149b338cc2af4 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A48617 | A48617 Beckman Access SHBG RGT 2x50T | — | 52610 | 9 completed purchases over 364 days; median interval 44.5 days; expected reorder 2026-07-29; Suppressed by Open Order by 12 days. | 525 | 700 | 875 | 247.5 | 330 | 412.5 | 65.89 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-427d184d0e09b1f0197e5603ede5a1acfcc42dd228df04d7a42433b7545f2b17 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ec32087f0bff4cd1aea1f8e994ac882a30c039feb553e75873e3c5ef6ece22d1 | OPP-cb8ebb87abcae887ece0961f7642a87360a3e92dc6af6bc17dc73f889d96fa88 | SER-92e35fc5f8c8f4f8e4c2b66ab774e70dfcfa2448aea3adefaf36c91bfc9e72b8 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A13422 | A13422 T3 FREE RGT 100/BX | — | 52610 | 10 completed purchases over 315 days; median interval 26.0 days; expected reorder 2026-07-18; Suppressed by Open Order by 23 days. | 393.75 | 525 | 656.25 | 150.86 | 201.15 | 251.44 | 65.69 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-ec32087f0bff4cd1aea1f8e994ac882a30c039feb553e75873e3c5ef6ece22d1 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-72b776f780d393949d127f2ccb347129dc5c7fa9fa546be7f1485bba00f3deaa | OPP-c20b6ee6f4621efc0b0e09e42ae536902626502105fa7d6d4234cffb549d3221 | SER-692677edd1ba65f0fb415f2913afc4c3c5e5f48bf632fc6939346b733362527a | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | Vendor | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Horiba | Horiba | 5300000496 | DIFFTROL Tri-Level 6 x 3mL | — | 52947 | 12 completed purchases over 364 days; median interval 27.0 days; expected reorder 2026-08-07; Overdue by 3 days. | 247.31 | 329.74 | 412.18 | 70.66 | 94.21 | 117.76 | 65.31 | Medium | False | False | — | CALL | Candidate CAND-72b776f780d393949d127f2ccb347129dc5c7fa9fa546be7f1485bba00f3deaa | Customer 41770 | Order 52947 | Item 14767 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-acdd9dd8ebc8dc44f67532b0e259022ebbdb238448b4eb44061fab5ed6605166 | OPP-bb03f403a146c551819014bc757807b3612bcb7c0558ef4f6f9a2532b2800a83 | SER-80626c3af3433fecd7fa7cc4fe2f6baf6138c41fe7db42e43d42f6ae07fdcdd3 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33560 | 33560 Beckman Access Testosterone | — | 52610 | 10 completed purchases over 315 days; median interval 27.0 days; expected reorder 2026-07-18; Overdue by 23 days. | 210 | 280 | 350 | 91.95 | 122.6 | 153.25 | 65.1 | Medium | False | False | — | CALL | Candidate CAND-acdd9dd8ebc8dc44f67532b0e259022ebbdb238448b4eb44061fab5ed6605166 | Customer 41770 | Order 52610 | Item 5019 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-328525aa8073b03b53c8c5f9fd70a9258a806428b372032112f30c58f2edbda1 | OPP-e9c7b0fb73eb7d6e86d93008167b16326b049b70d2b027ab6a3458b267564ff4 | SER-f931c8c9fd8c49587ffb562b6309ca9407ab385fff0f13dfa6057d541cfecf4e | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A16792 | A16792 Beckman Access Wash Buffer, Pkg/4 bottles, 1.9 L/bottle | — | 52610 | 13 completed purchases over 364 days; median interval 25.0 days; expected reorder 2026-07-19; Suppressed by Open Order by 22 days. | 306.25 | 408.33 | 510.42 | 120.15 | 160.2 | 200.25 | 64.51 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-328525aa8073b03b53c8c5f9fd70a9258a806428b372032112f30c58f2edbda1 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b2c024f159455dfdede5328dcba3f26c0dc3930e199f9c3ea4d2dc1029d0f7a3 | OPP-e889139579a5ecc76740c7f67fd19f43b5cdb4ed76ef510913addb686a336e58 | SER-132f25eb9955bf81502cd6e2e96f1e73fed17fb90b92afbf19705c15b7ce2b16 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | B63284 | B63284 Beckman Access TSH (3rd IS) 2x100 Det | — | 52610 | 10 completed purchases over 352 days; median interval 27.0 days; expected reorder 2026-07-18; Suppressed by Open Order by 23 days. | 262.5 | 350 | 437.5 | 154.5 | 206 | 257.5 | 63.89 | Low | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-b2c024f159455dfdede5328dcba3f26c0dc3930e199f9c3ea4d2dc1029d0f7a3 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0a0428ca866e7e7f8c8fac22c5b40c3098fe1cb22f9ebacbcc88a5b736510deb | OPP-122794d7ff20838510869f4f30cacc9d58cf05acb4736b69212d3a76b9df69ec | SER-f9849a8e24803592d3f392259a6157290a29536507d7680833be780da6403a1c | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33000 | 33000 Beckman Access B12 Reagent 100/BX | — | 52610 | 13 completed purchases over 352 days; median interval 23.5 days; expected reorder 2026-07-17; Suppressed by Open Order by 24 days. | 272.5 | 363.33 | 454.17 | 113.29 | 151.05 | 188.81 | 62.61 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-0a0428ca866e7e7f8c8fac22c5b40c3098fe1cb22f9ebacbcc88a5b736510deb | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3430e0835666e47d1d94a48cbd7869fb92649a46e7c9304242ecaedde36787b7 | OPP-089137564eca173078f659db1907d271b3a8ab146d235a4bcb6cd2f13d98d1b9 | SER-914a2d4af62bc4167b2a5b985fba40006c76bdeededff74fbfa74388bea3f269 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 81901 | 81901 Beckman Access Cuvette Reaction Vessels | — | 52610 | 15 completed purchases over 364 days; median interval 24.0 days; expected reorder 2026-07-18; Suppressed by Open Order by 23 days. | 179.73 | 239.64 | 299.55 | 42.99 | 57.32 | 71.65 | 62.53 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-3430e0835666e47d1d94a48cbd7869fb92649a46e7c9304242ecaedde36787b7 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-870750ebd2143258622095eedbedd116503a42c586134cfca1d2d2a594e4d728 | OPP-9f25ddee2b936d296a29bd3609d756775ce7efb0993e968da5f54ae0ef8367fc | SER-c91b06576553b3de3e3d23efe3dac9e0de918c365fbacfd263822817f9656163 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 37210 | 37210 BECKMAN ACCESS PSA HYBRTCH FREE 100S | — | 52168 | 8 completed purchases over 325 days; median interval 35.0 days; expected reorder 2026-07-18; Suppressed by Open Order by 23 days. | 219.6 | 292.8 | 366 | 115.97 | 154.62 | 193.28 | 61.97 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-870750ebd2143258622095eedbedd116503a42c586134cfca1d2d2a594e4d728 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d81b4e4bd7525fa5cf3a7bd0ff86826a6aca2bc9a4815c75916082f9cf60ff83 | OPP-adcd6e55473b14480f4293fcb00ffb5dc298c0082af45e7836f9d36e5dc717e1 | SER-461c29833d86e03fb2885b9efb26deff429ea8932e9355f137b35b4770099cba | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 81906 | 81906 Beckman Access Substrate | — | 52610 | 14 completed purchases over 364 days; median interval 19.0 days; expected reorder 2026-07-16; Suppressed by Open Order by 25 days. | 131.25 | 175 | 218.75 | 56.06 | 74.75 | 93.44 | 61.42 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-d81b4e4bd7525fa5cf3a7bd0ff86826a6aca2bc9a4815c75916082f9cf60ff83 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f67f45146d5ce72094f4f651cab46c0da5db79370a4f86c615a1a4d99a7c41b1 | OPP-9fce32e7f82def9915aa846f437e02f68be8e590cff48e94315d34d53bdc4d8b | SER-2335929be11c2e704ae164938214ee2f1d3b341a37112546083bb5bafd2e7845 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33510 | 33510 BECKMAN ACCESS hLH, 100/BX | — | 52610 | 7 completed purchases over 352 days; median interval 48.5 days; expected reorder 2026-08-02; Overdue by 8 days. | 193.5 | 258 | 322.5 | 136.58 | 182.1 | 227.63 | 61.27 | High | False | False | — | CALL | Candidate CAND-f67f45146d5ce72094f4f651cab46c0da5db79370a4f86c615a1a4d99a7c41b1 | Customer 41770 | Order 52610 | Item 4954 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-35018190d91de761469a5574d67548099c2007327d530a41b54484e2239d19b6 | OPP-029ec7d5c2cfdf89a459a2e8bd3465028566be1156efce482a4055ad03169936 | SER-be471ee956dede1c481fd30d8fcdcc88abe9e379893fc10244bd1ea2d36f2bac | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33830 | 33830 BECKMAN ACCESS TOTAL T3 RGT 100/BX | — | 52610 | 9 completed purchases over 352 days; median interval 35.5 days; expected reorder 2026-07-23; Suppressed by Open Order by 18 days. | 187.5 | 250 | 312.5 | 82.64 | 110.18 | 137.73 | 61.18 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-35018190d91de761469a5574d67548099c2007327d530a41b54484e2239d19b6 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ac6f916cbb1d93c3fb105a5e285cd2057862a9330e6e62ec569d1d011272ae03 | OPP-eb086aca155df6a8b4e385777db5be1e75025eea960f51812c3601b35e1144d5 | SER-558024a15e66a05b17000b9818b1ca48e5d65abaf7f10c326eab4e767c6882ff | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6137 | OSR6137 Olympus CO2 Reagent (4x580 tests) | — | 52168 | 6 completed purchases over 325 days; median interval 71.0 days; expected reorder 2026-08-03; Overdue by 7 days. | 297.34 | 396.45 | 495.56 | 122.09 | 162.78 | 203.48 | 58.58 | High | False | False | — | CALL | Candidate CAND-ac6f916cbb1d93c3fb105a5e285cd2057862a9330e6e62ec569d1d011272ae03 | Customer 41770 | Order 52168 | Item 11335 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9c414e6f8a24c30be82ceea6efcc770a0bd961c5d3327504b17eee2f336d89c4 | OPP-0ee1eec094bf457d2109f3d6bd7f77f73b1bf530bf4bd1ffd0ccb0c73eab34c4 | SER-573b74bbae57017f40410117c04841a94052d43c0f5608089146c9b40611224d | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 37200 | 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | — | 52610 | 8 completed purchases over 352 days; median interval 37.0 days; expected reorder 2026-08-20; Suppressed by Open Order in 10 days. | 297 | 396 | 495 | 195.68 | 260.9 | 326.13 | 57.96 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-9c414e6f8a24c30be82ceea6efcc770a0bd961c5d3327504b17eee2f336d89c4 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9127ff4aa6176ce0dc5984670e80b335ffdae94e2ec5ad4ecf3fcb9efe0a3c59 | OPP-eb597a839ee78820b69999c31dc8a92633b3e058c9b4b3b2f64bb0cdedf57712 | SER-0c0ea94f5b293f7e3f2c1ff45840c7b9af3df49501d83cb6ce9f8120fc9a22be | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6178 | Olympus OSR6178 CREATININE Reagent (4x990 tests) | — | 51426 | 5 completed purchases over 280 days; median interval 67.5 days; expected reorder 2026-06-17; High Risk by 54 days. | 150 | 200 | 250 | 68.25 | 91 | 113.75 | 57.92 | Medium | False | False | — | CALL | Candidate CAND-9127ff4aa6176ce0dc5984670e80b335ffdae94e2ec5ad4ecf3fcb9efe0a3c59 | Customer 41770 | Order 51426 | Item 10576 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-588a0edfeb01825f6c9492819b5279c53ca69115d1b8164f996eb36aa0185501 | OPP-0f235e0ffaef6557444d3c2777d2f6799b18a84669f045d0a447be8296f03eec | SER-d15d32f3c04fac992fb4aa4b2e92d3698694b2650626dd47db8d0a9c714bba60 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A10826 | A10826 Beckman Access DHEA-S RGT | — | 52610 | 7 completed purchases over 364 days; median interval 53.5 days; expected reorder 2026-08-27; Suppressed by Open Order in 17 days. | 340 | 453.33 | 566.67 | 184.5 | 246 | 307.5 | 57.78 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-588a0edfeb01825f6c9492819b5279c53ca69115d1b8164f996eb36aa0185501 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0f941102e3995f95fd3d5cfc1c483024d090587e08121acc1e5d433ac98d95b3 | OPP-55b549b895bbbaaf9a4f0cad41d179e19dbf342ad37659bdb80dca20ed211ae0 | SER-2a2684c2f732f4c442841eced3dd3fef7d93d2418a0c2a1f86f3f2d4ca4dc704 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33520 | 33520 BECKMAN ACCESS hFSH, 100/BX | — | 52946 | 10 completed purchases over 372 days; median interval 36.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | 112.5 | 150 | 187.5 | 55.58 | 74.1 | 92.63 | 57.44 | Medium | False | False | — | CALL | Candidate CAND-0f941102e3995f95fd3d5cfc1c483024d090587e08121acc1e5d433ac98d95b3 | Customer 41770 | Order 52946 | Item 4953 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a0fb7b94b0562734cd2b625ceab5523e4dd0654f48df7e073c20f47b00816534 | OPP-e64b2de86e6ceaa01ef44c7538c752bad6ffa94dfd5c510f357f30ab2d61a328 | SER-b7cd41ba67c6443b4a9d95460e533dbca3386fdb29afd2fd6d4185f430bd3c84 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33550 | 33550 Beckman Access PROG RGT | — | 52610 | 8 completed purchases over 315 days; median interval 36.0 days; expected reorder 2026-08-20; Suppressed by Open Order in 10 days. | 131.25 | 175 | 218.75 | 54 | 72 | 90 | 56.6 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-a0fb7b94b0562734cd2b625ceab5523e4dd0654f48df7e073c20f47b00816534 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-94add5d84d50d8c1ca63a51f92d75cd95fc3c4280fd310903d8a384cb183381d | OPP-8102a16b715ca1e8a37f9ae5814a77edd18314e199e89dc04cc8dbb67f6b9c97 | SER-3bdbc91180be4a0c448d2d5230d2cc42573079bd4fd125f2e53faeae0310f6f7 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33800 | 33800 BECKMAN ACCESS TOTAL T4 RGT 100/BX | — | 52610 | 8 completed purchases over 344 days; median interval 36.0 days; expected reorder 2026-08-20; Due Soon in 10 days. | 210 | 280 | 350 | 84.48 | 112.64 | 140.79 | 55.81 | Medium | False | False | — | CALL | Candidate CAND-94add5d84d50d8c1ca63a51f92d75cd95fc3c4280fd310903d8a384cb183381d | Customer 41770 | Order 52610 | Item 4252 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dca93b71437c75a8c286d482dee4170042aa51b75a1a91cc1011c989668c2aa9 | OPP-0611530468198d587f860292281cab910fcb1a32f873080467b3f49272678174 | SER-d989980a171840b4c5c3e3516f6ca8846040b9968fa899c648a744fbb3644098 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | A16972 | A16972 BECKMAN ACCESS INTACT PTH 2X50TST | — | 52610 | 5 completed purchases over 229 days; median interval 63.5 days; expected reorder 2026-08-14; Due Soon in 4 days. | 437.5 | 583.33 | 729.17 | 209.25 | 279 | 348.75 | 55.21 | Medium | False | False | — | CALL | Candidate CAND-dca93b71437c75a8c286d482dee4170042aa51b75a1a91cc1011c989668c2aa9 | Customer 41770 | Order 52610 | Item 4250 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-572d53f1f7c45c0a61facace84a738efc924c2075fccb134a308d72a3c954c18 | OPP-f29ad1571b8d6479d97bd79bdf9ab36bf55860f24ddbbb4500d6d7e09e397b75 | SER-51522a0d74f5c8283eba1227d3d32ba72912b393df22d3abe324da83024aa235 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33410 | 33410 Beckman Access Ultrasensitive Insulin Reagent Pack, 100 /box | — | 52610 | 6 completed purchases over 315 days; median interval 45.0 days; expected reorder 2026-08-23; Suppressed by Open Order in 13 days. | 225 | 300 | 375 | 129.75 | 173 | 216.25 | 53.74 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-572d53f1f7c45c0a61facace84a738efc924c2075fccb134a308d72a3c954c18 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | OPP-f4e954b27108c7fd81d0838502069f6080281bd318ca631ae6379998f9f0716d | SER-a5db9bfcf6edaf72e575f3903b0043f4d4420993659bc8a59acfe68837dce64b | Needs Validation | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6006 | OSR6006 Olympus Amylase Reagent (4x10ml) | — | 52168 | 3 completed purchases over 121 days; median interval 60.5 days; expected reorder 2026-07-27; Overdue by 14 days. | 165.09 | 220.12 | 275.15 | 130.59 | 174.12 | 217.65 | 53.08 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1d4b5814b6867d980f171d4faeed57e702765a0d656104414e9bfc4454ceca68 | OPP-f3fe516e93e500dc9544817dc5a202396f39c751b28ec2124f7bae7754c8778a | SER-4cebc6a414322e48740013036a30a7f02bf4e006a5b422a71ca58caa143598fe | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33530 | 33530 BECKMAN ACCESS PROLACTIN, 100/BX | — | 52610 | 6 completed purchases over 338 days; median interval 69.0 days; expected reorder 2026-09-02; Suppressed by Open Order in 23 days. | 131.25 | 175 | 218.75 | 54 | 72 | 90 | 52.2 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-1d4b5814b6867d980f171d4faeed57e702765a0d656104414e9bfc4454ceca68 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f3a28fd625969bc03a4441e65101f423d27b958f35539de69881f699230b047f | OPP-b2d2144bd82fce63e16169edf9f51b95c5e9dc67e0fd157fdad755db90905894 | SER-755b8f2d8b3c402348d4a5f55cf1eb74aeb475509da41d1ff656d38c54a2056f | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33600 | 33600 BECKMAN ACCESS CORTISOL RGT 100/BX | — | 52610 | 6 completed purchases over 300 days; median interval 45.0 days; expected reorder 2026-08-23; Suppressed by Open Order in 13 days. | 105 | 140 | 175 | 38.63 | 51.5 | 64.38 | 50.67 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-f3a28fd625969bc03a4441e65101f423d27b958f35539de69881f699230b047f | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | OPP-f10490c290aed4f041fb886d129b825b5f25de817ade6ec56160272bb9c7d71e | SER-d46c3659d9b9501b0d80889799c3e11a1fe23d9cbccf02a28e142d419e0c1672 | Needs Validation | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6132 | OSR6132 Olympus TP Reagent (4x750 tests) | — | 51426 | 3 completed purchases over 209 days; median interval 104.5 days; expected reorder 2026-07-26; Overdue by 15 days. | 112.5 | 150 | 187.5 | 70.24 | 93.65 | 117.06 | 48.21 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-df8e69fd242aa88a2f331d33a0ed51ff3b5724e2a099ee130b3d690b96e29192 | OPP-4c46795742b4c3b8daa28a502d82c2d3bbc4746c88834cb76c85d6543a15f82a | SER-e00fb404e9c0340c44904c777698e4c92bba04ee6058df4fefc368926157f948 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6102 | OSR6102 Olympus Albumin Reagent (4x620 tests) | — | 51426 | 3 completed purchases over 228 days; median interval 114.0 days; expected reorder 2026-08-04; Suppressed by Open Order by 6 days. | 78.75 | 105 | 131.25 | 63 | 84 | 105 | 46.69 | Low | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-df8e69fd242aa88a2f331d33a0ed51ff3b5724e2a099ee130b3d690b96e29192 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cec97aadefa527d23ef1a4182ed5d5f8e8a80414521a3c16604985d1352be8b0 | OPP-d27ec940782b6465476bb362fd0ca574007e4e2a7f87cc5bd0f366beaa8ed2f2 | SER-09743d1aee74cd34c8ea94e7273d4f748394f6b8980a4670b0e0794d8749ca73 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Olympus / Beckman AU | Olympus | OSR6111 | DBIL (Direct Bilirubin) Reagent, 4 x 6 mL & 4 x 6 mL | — | 52168 | 4 completed purchases over 206 days; median interval 52.0 days; expected reorder 2026-07-28; Suppressed by Open Order by 13 days. | 30.53 | 40.71 | 50.89 | 5.95 | 7.93 | 9.91 | 46.65 | Low | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-cec97aadefa527d23ef1a4182ed5d5f8e8a80414521a3c16604985d1352be8b0 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e7fd3aa43d217c4411134349dd44994b265f69757c55f0053f2fa266eaab46a6 | OPP-65a673035315572d74f5e5d2ba8358b927877545e653cb478e53e36e1cddee86 | SER-e94e6f800bd5ea0ebb8378386e5375a5b6d39e7bf2a2cb148db501346ee95ed8 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | B24839 | B24839 Access 25(OH) Vitamin D Calibrators (for use on Access 2 Immunoassay Systems) (S0-S5) | — | 52168 | 4 completed purchases over 254 days; median interval 107.0 days; expected reorder 2026-08-29; Suppressed by Open Order in 19 days. | 114.28 | 152.37 | 190.46 | 28.57 | 38.09 | 47.61 | 43.59 | Medium | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-e7fd3aa43d217c4411134349dd44994b265f69757c55f0053f2fa266eaab46a6 | Customer 41770 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dbc0e06b882ba8f40b0bfef4f694c9d586a2a4e9c9d06aa83068da15771ffb20 | OPP-77a0c4053358a184c1d981cd1f0bc3034491d956429dc50c52e1d5b8c32a989f | SER-8f6f6e49d9b1c553dd2454615929c78d4dae5f7d1f48661865e84dde180eef09 | Suppressed by Open Order | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | Hoffman Estates | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 33565 | 33565 Beckman Access Testosterone Calibrators (S0-S5), 1 set, 6 x 4.0 ml | — | 51799 | 3 completed purchases over 229 days; median interval 114.5 days; expected reorder 2026-08-26; Suppressed by Open Order in 16 days. | 56.25 | 75 | 93.75 | 20.25 | 27 | 33.75 | 41.37 | Low | True | False | Open Order | MANAGER_REVIEW | Candidate CAND-dbc0e06b882ba8f40b0bfef4f694c9d586a2a4e9c9d06aa83068da15771ffb20 | Customer 41770 |
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-76dd5e77797ca402c1ca1530f9a994207d56f3d29103f28a5ba1eeeb1a789eea | OPP-b12c46070df5d2f5f0f610e1899caf99910e02a021d5c16739fbdc8e558f4911 | SER-a6bdc871763bbfc143cb7793153fb3e084823c321adccc3e8c08b0812b22cdf5 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | — | Hoffman Estates | IL | Midwest | End-User Laboratory | High | — | Parts Group | Dynex-DSX-R | Dynex DSX, Refurbished | 30145 | — | Stale Open Quote on quote 30145; quote age 132 days; last modified 131 days ago; quoted value $30250.00; converted line value $0.00; unconverted line value $30250.00. | 3025 | 6050 | 9075 | — | — | — | 69.13 | Medium | False | True | — | RESEND_QUOTE | Candidate CAND-76dd5e77797ca402c1ca1530f9a994207d56f3d29103f28a5ba1eeeb1a789eea | Customer 41770 | Quote 30145 | Item 12675 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d8c13bf38c8e466c833ba23085fd6a6e939cfdbcf01ea1810cdcdb3d101f33f2 | OPP-a0a284fc38b84cbd068cb51967184173d5eaf155716a316fcc9021eae0d67ada | SER-75d82c981ef7f3dfbc6cc5214af358f8c083fdee91446eaeb4d699c0abb4cc08 | Published | **** | **** | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | St. Charles | IL | Midwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 81906 | 81906 Beckman Access Substrate | — | — | Verified by Description for Beckman Access / DxI; item purchased by 23 of 40 comparable active sites (57.5%); peer median annual revenue $857.50. | 428.75 | 857.5 | 1286.25 | 238 | 476 | 714 | 69.83 | High | False | False | — | CONFIRM_ANALYZER | Candidate CAND-d8c13bf38c8e466c833ba23085fd6a6e939cfdbcf01ea1810cdcdb3d101f33f2 | Customer 41770 | Item 4877 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | OPP-9071b47ae445ecb1eb90fabad158d04ad4c2e23eb3eee5fb6d8ab84ea1b9cd7e | SER-caafaa340c0356fa4c4488ab7edba0741c72511d42456f37d8a22dc8e550736a | — | **** | — | — | Lakeside Clinical Group, Inc. | 41770 | HQ | — | IL | — | — | — | Beckman Access / DxI | — | — | — | — | — | 10 completed purchases over 272 days; median interval 19.0 days; expected reorder 2026-05-19; High Risk by 83 days. | — | 315 | — | — | 208.57 | — | 66.83 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | Customer 41770 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | OPP-f4e954b27108c7fd81d0838502069f6080281bd318ca631ae6379998f9f0716d | SER-a5db9bfcf6edaf72e575f3903b0043f4d4420993659bc8a59acfe68837dce64b | — | **** | — | — | Lakeside Clinical Group, Inc. | 41770 | HQ | — | IL | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 3 completed purchases over 121 days; median interval 60.5 days; expected reorder 2026-07-27; Overdue by 14 days. | — | 220.12 | — | — | 174.12 | — | 53.08 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | Customer 41770 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | OPP-f10490c290aed4f041fb886d129b825b5f25de817ade6ec56160272bb9c7d71e | SER-d46c3659d9b9501b0d80889799c3e11a1fe23d9cbccf02a28e142d419e0c1672 | — | **** | — | — | Lakeside Clinical Group, Inc. | 41770 | HQ | — | IL | — | — | — | Olympus / Beckman AU | — | — | — | — | — | 3 completed purchases over 209 days; median interval 104.5 days; expected reorder 2026-07-26; Overdue by 15 days. | — | 150 | — | — | 93.65 | — | 48.21 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | Customer 41770 |